Clinical Trial

REGistry of Long-term AnTithrombotic TherApy-1

Study acronym: REGATTA-1
Recruiting
View on ClinicalTrials.gov →
Summary
To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with chronic coronary syndromes
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2020-04-14; most recent amendment 2026-04-27.
Trial Details
NCT Number NCT04347200
Lead Sponsor National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Conditions Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)), Peripheral Artery Disease
Enrollment 2,000 participants
Start Date 2015-01-15
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-01